News

Imagion Biosystems Begins Clinical Studies on MagSense Particles for Cancer Detection

 Imagion Biosystems is progressing to clinical studies of the efficacy of its MagSense magnetic particles for early detection of cancer, marking an important advancement for the Melbourne biotech firm that is pioneering the application of magnetic particles beyond […]

Materials/Manufacturing

Imagion Biosystems Receives $300K Order for Its Magnetic Nanoparticles

Imagion Biosystems Ltd. has announced that NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has placed an order totaling approximately $300,000 for the supply of Imagion’s magnetic nanoparticles. Headquartered in Melbourne, Australia, Imagion is a developer of magnetic nanoparticles and a […]